Search

everythinglearnresearchcommunity

for

Search:↓

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

A young woman with skin issues and weight loss improved after treating her pancreatitis and using skin treatments.

GLP-1RA therapy may increase the risk of hair loss.

Hair glycation can indicate long-term blood sugar trends in diabetics.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

GLP-1 agonists may increase the risk of hair loss.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Glycosylated keratin levels in hair can help identify the onset of insulin-dependent diabetes.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Hair chromium levels might indicate chromium status and relate to glucose metabolism issues.

Low prolactin in young women may increase heart and metabolism risks.

Hair conditions can be linked to diabetes and affect psychological health.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

GLP-1 receptor agonists may help or harm hair health, needing more research.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Switching insulin brands caused skin lesions in a diabetic woman, resolved by changing to oral medication.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Overweight and obese children in Bangladesh show signs of altered glucose metabolism, indicating a need for screening.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

GLP-1 receptor agonists may cause hair loss, but more research is needed.